Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Potkin

Showing results (111-120 of 217) with videos related to

Pageof 22
Sort By:
The International Journal of Neuropsychopharmacology|December 9, 2016
Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone PalmitateSteven G Potkin, Jean-Yves Loze, Carlos Forray, et al.
Neurobiology of Aging|June 12, 2010
Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohortAnita Lakatos, Olga Derbeneva, Danny Younes, et al.
Frontiers in Human Neuroscience|February 29, 2012
An ICA with reference approach in identification of genetic variation and associated brain networksJingyu Liu, Mohammad M Ghassemi, Andrew M Michael, et al.
International Clinical Psychopharmacology|March 3, 2017
Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFYSteven G Potkin, Jean-Yves Loze, Carlos Forray, et al.
Schizophrenia Research|August 2, 2015
Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophreniaDieter Naber, Karina Hansen, Carlos Forray, et al.
Neuroimage. Clinical|December 21, 2016
Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adultsClare Kelly, F Xavier Castellanos, Olivia Tomaselli, et al.
Schizophrenia Research|December 17, 2013
Converting positive and negative symptom scores between PANSS and SAPS/SANSTheo G M van Erp, Adrian Preda, Dana Nguyen, et al.
Genomics|April 16, 2013
Increased CNV-region deletions in mild cognitive impairment (MCI) and Alzheimer's disease (AD) subjects in the ADNI sampleGuia Guffanti, Federica Torri, Jerod Rasmussen, et al.
Schizophrenia Research|June 25, 2018
A positive take on schizophrenia negative symptom scales: Converting scores between the SANS, NSA and SDSAdrian Preda, Dana D Nguyen, Juan R Bustillo, et al.
Frontiers in Psychiatry|August 10, 2019
Altered Domain Functional Network Connectivity Strength and Randomness in SchizophreniaVictor M Vergara, Eswar Damaraju, Jessica A Turner, et al.
Pageof 22

Showing results (111-120 of 217) with videos related to

Sort By:
Pageof 22
The International Journal of Neuropsychopharmacology|December 9, 2016
Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone PalmitateSteven G Potkin, Jean-Yves Loze, Carlos Forray, et al.
Neurobiology of Aging|June 12, 2010
Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohortAnita Lakatos, Olga Derbeneva, Danny Younes, et al.
Frontiers in Human Neuroscience|February 29, 2012
An ICA with reference approach in identification of genetic variation and associated brain networksJingyu Liu, Mohammad M Ghassemi, Andrew M Michael, et al.
International Clinical Psychopharmacology|March 3, 2017
Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFYSteven G Potkin, Jean-Yves Loze, Carlos Forray, et al.
Schizophrenia Research|August 2, 2015
Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophreniaDieter Naber, Karina Hansen, Carlos Forray, et al.
Neuroimage. Clinical|December 21, 2016
Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adultsClare Kelly, F Xavier Castellanos, Olivia Tomaselli, et al.
Schizophrenia Research|December 17, 2013
Converting positive and negative symptom scores between PANSS and SAPS/SANSTheo G M van Erp, Adrian Preda, Dana Nguyen, et al.
Genomics|April 16, 2013
Increased CNV-region deletions in mild cognitive impairment (MCI) and Alzheimer's disease (AD) subjects in the ADNI sampleGuia Guffanti, Federica Torri, Jerod Rasmussen, et al.
Schizophrenia Research|June 25, 2018
A positive take on schizophrenia negative symptom scales: Converting scores between the SANS, NSA and SDSAdrian Preda, Dana D Nguyen, Juan R Bustillo, et al.
Frontiers in Psychiatry|August 10, 2019
Altered Domain Functional Network Connectivity Strength and Randomness in SchizophreniaVictor M Vergara, Eswar Damaraju, Jessica A Turner, et al.
Pageof 22